|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wong H and Yau T: Targeted therapy in the
management of advanced gastric cancer: Are we making progress in
the era of personalized medicine? Oncologist. 17:346–358. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Suzuki HI, Katsura A, Matsuyama H and
Miyazono K: MicroRNA regulons in tumor microenvironment. Oncogene.
34:3085–3094. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Peng CW, Tian Q, Yang GF, Fang M, Zhang
ZL, Peng J, Li Y and Pang DW: Quantum-dots based simultaneous
detection of multiple biomarkers of tumor stromal features to
predict clinical outcomes in gastric cancer. Biomaterials.
33:5742–5752. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee K, Hwang H and Nam KT: Immune response
and the tumor microenvironment: How they communicate to regulate
gastric cancer. Gut Liver. 8:131–139. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim JW, Nam KH, Ahn SH, Park DJ, Kim HH,
Kim SH, Chang H, Lee JO, Kim YJ, Lee HS, et al: Prognostic
implications of immunosuppressive protein expression in tumors as
well as immune cell infiltration within the tumor microenvironment
in gastric cancer. Gastric Cancer. 19:42–52. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lauren P: The two histological main types
of gastric carcinoma: Diffuse and so-called intestinal-type
carcinoma. An attempt at a histo-clinical classification. Acta
Pathol Microbiol Scand. 64:31–49. 1965. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim MG, Shon Y, Kim J and Oh YK: Selective
activation of anticancer chemotherapy by cancer-associated
fibroblasts in the tumor microenvironment. J Natl Cancer Inst.
109:pii: djw1862017. View Article : Google Scholar
|
|
9
|
Kanemaru A, Yamamoto K, Kawaguchi M,
Fukushima T, Lin CY, Johnson MD, Camerer E and Kataoka H:
Deregulated matriptase activity in oral squamous cell carcinoma
promotes the infiltration of cancer-associated fibroblasts by
paracrine activation of protease-activated receptor 2. Int J
Cancer. 140:130–141. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ouyang L, Chang W, Fang B, Qin J, Qu X and
Cheng F: Estrogen-induced SDF-1α production promotes the
progression of ER-negative breast cancer via the accumulation of
MDSCs in the tumor microenvironment. Sci Rep. 6:395412016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Karimi P, Islami F, Anandasabapathy S,
Freedman ND and Kamangar F: Gastric cancer: Descriptive
epidemiology, risk factors, screening and prevention. Cancer
Epidemiol Biomarkers Prev. 23:700–713. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Quante M, Tu SP, Tomita H, Gonda T, Wang
SS, Takashi S, Baik GH, Shibata W, Diprete B, Betz KS, et al: Bone
marrow-derived myofibroblasts contribute to the mesenchymal stem
cell niche and promote tumor growth. Cancer cell. 19:257–272. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Räsänen K and Vaheri A: Activation of
fibroblasts in cancer stroma. Exp Cell Res. 316:2713–2722. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang J, Lu Y, Lin YY, Zheng ZY, Fang JH,
He S and Zhuang SM: Vascular mimicry formation is promoted by
paracrine TGF-β and SDF1 of cancer-associated fibroblasts and
inhibited by miR-101 in hepatocellular carcinoma. Cancer Lett.
383:18–27. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xia Q, Zhang FF, Geng F, Liu CL, Wang YQ,
Xu P, Lu ZZ, Xie Y, Wu H, Chen Y, et al: Improvement of anti-tumor
immunity of fibroblast activation protein α based vaccines by
combination with cyclophosphamide in a murine model of breast
cancer. Cell Immunol. 310:89–98. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Polanska UM and Orimo A:
Carcinoma-associated fibroblasts: Non-neoplastic tumour-promoting
mesenchymal cells. J Cell Physiol. 228:1651–1657. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Maeda K, Chung YS, Ogawa Y, Takatsuka S,
Kang SM, Ogawa M, Sawada T and Sowa M: Prognostic value of vascular
endothelial growth factor expression in gastric carcinoma. Cancer.
77:858–863. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Terai S, Fushida S, Tsukada T, Kinoshita
J, Oyama K, Okamoto K, Makino I, Tajima H, Ninomiya I, Fujimura T,
et al: Bone marrow derived ‘fibrocytes’ contribute to tumor
proliferation and fibrosis in gastric cancer. Gastric Cancer.
18:306–313. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang TS, Yang XH, Chen X, Wang XD, Hua J,
Zhou DL, Zhou B and Song ZS: MicroRNA-106b in cancer-associated
fibroblasts from gastric cancer promotes cell migration and
invasion by targeting PTEN. FEBS Lett. 588:2162–2169. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gu J, Qian H, Shen L, Zhang X, Zhu W,
Huang L, Yan Y, Mao F, Zhao C, Shi Y and Xu W: Gastric cancer
exosomes trigger differentiation of umbilical cord derived
mesenchymal stem cells to carcinoma-associated fibroblasts through
TGF-β/Smad pathway. PloS one. 7:e524652012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fuyuhiro Y, Yashiro M, Noda S, Kashiwagi
S, Matsuoka J, Doi Y, Kato Y, Hasegawa T, Sawada T and Hirakawa K:
Upregulation of cancer-associated myofibroblasts by TGF-β from
scirrhous gastric carcinoma cells. Brit J Cancer. 105:996–1001.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Han ME, Kim HJ, Shin DH, Hwang SH, Kang CD
and Oh SO: Overexpression of NRG1 promotes progression of gastric
cancer by regulating the self-renewal of cancer stem cells. J
Gastroenterol. 50:645–656. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kikuchi Y, Kunita A, Iwata C, Komura D,
Nishiyama T, Shimazu K, Takeshita K, Shibahara J, Kii I, Morishita
Y, et al: The niche component periostin is produced by
cancer-associated fibroblasts, supporting growth of gastric cancer
through ERK activation. Am J Pathol. 184:859–870. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Goetz JG, Minguet S, Navarro-Lérida I,
Lazcano JJ, Samaniego R, Calvo E, Tello M, Osteso-Ibáñez T,
Pellinen T, Echarri A, et al: Biomechanical remodeling of the
microenvironment by stromal caveolin-1 favors tumor invasion and
metastasis. Cell. 146:148–163. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Erez N, Truitt M, Olson P, Arron ST and
Hanahan D: Cancer-associated fibroblasts are activated in incipient
neoplasia to orchestrate tumor-promoting inflammation in an
NF-kappaB-dependent manner. Cancer cell. 17:135–147. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Semba S, Kodama Y, Ohnuma K, Mizuuchi E,
Masuda R, Yashiro M, Hirakawa K and Yokozaki H: Direct
cancer-stromal interaction increases fibroblast proliferation and
enhances invasive properties of scirrhous-type gastric carcinoma
cells. Brit J Cancer. 101:1365–1373. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tsukada T, Fushida S, Harada S, Yagi Y,
Kinoshita J, Oyama K, Tajima H, Fujita H, Ninomiya I, Fujimura T
and Ohta T: The role of human peritoneal mesothelial cells in the
fibrosis and progression of gastric cancer. Int J Oncol.
41:476–482. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fukui H, Zhang X, Sun C, Hara K, Kikuchi
S, Yamasaki T, Kondo T, Tomita T, Oshima T, Watari J, et al: IL-22
produced by cancer-associated fibroblasts promotes gastric cancer
cell invasion via STAT3 and ERK signaling. Br J Cancer.
111:763–771. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
He XJ, Tao HQ, Hu ZM, Ma YY, Xu J, Wang
HJ, Xia YJ, Li L, Fei BY, Li YQ and Chen JZ: Expression of
galectin-1 in carcinoma-associated fibroblasts promotes gastric
cancer cell invasion through upregulation of integrin β1. Cancer
Sci. 105:1402–1410. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sun C, Fukui H, Hara K, Zhang X, Kitayama
Y, Eda H, Tomita T, Oshima T, Kikuchi S, Watari J, et al: FGF9 from
cancer-associated fibroblasts is a possible mediator of invasion
and anti-apoptosis of gastric cancer cells. BMC Cancer. 15:3332015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sung CO, Lee KW, Han S and Kim SH: Twist1
is up-regulated in gastric cancer-associated fibroblasts with poor
clinical outcomes. Am J Pathol. 179:1827–1838. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Song YH, Zhu YT, Ding J, Zhou FY, Xue JX,
Jung JH, Li ZJ and Gao WY: Distribution of fibroblast growth
factors and their roles in skin fibroblast cell migration. Mol Med
Rep. 14:3336–3342. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang X, Ibrahimi OA, Olsen SK, Umemori H,
Mohammadi M and Ornitz DM: Receptor specificity of the fibroblast
growth factor family. The complete mammalian FGF family. J Biol
Chem. 281:15694–15700. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Basilico C and Moscatelli D: The FGF
family of growth factors and oncogenes. Adv Cancer Res. 59:115–165.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cao H, Xu W, Qian H, Zhu W, Yan Y, Zhou H,
Zhang X and Xu X, Li J, Chen Z and Xu X: Mesenchymal stem cell-like
cells derived from human gastric cancer tissues. Cancer Lett.
274:61–71. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Karnoub AE, Dash AB, Vo AP, Sullivan A,
Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R and Weinberg
RA: Mesenchymal stem cells within tumour stroma promote breast
cancer metastasis. Nature. 449:557–563. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xu X, Zhang X, Wang S, Qian H, Zhu W, Cao
H, Wang M, Chen Y and Xu W: Isolation and comparison of mesenchymal
stem-like cells from human gastric cancer and adjacent
non-cancerous tissues. J Cancer Res Clin Oncol. 137:495–504. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ponta H, Sherman L and Herrlich PA: CD44:
From adhesion molecules to signalling regulators. Nat Rev Mol Cell
Biol. 4:33–45. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yu B, Chen X, Li J, Qu Y, Su L, Peng Y,
Huang J, Yan J, Yu Y, Gu Q, et al: Stromal fibroblasts in the
microenvironment of gastric carcinomas promote tumor metastasis via
upregulating TAGLN expression. BMC Cell Biol. 14:172013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shimoda M, Mellody KT and Orimo A:
Carcinoma-associated fibroblasts are a rate-limiting determinant
for tumour progression. Semin Cell Dev Biol. 21:19–25. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bourget JM, Gauvin R, Larouche D, Lavoie
A, Labbé R, Auger FA and Germain L: Human fibroblast-derived ECM as
a scaffold for vascular tissue engineering. Biomaterials.
33:9205–9213. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Venning FA, Wullkopf L and Erler JT:
Targeting ECM disrupts cancer progression. Front Oncol. 5:2242015.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Pickup MW, Mouw JK and Weaver VM: The
extracellular matrix modulates the hallmarks of cancer. EMBO Rep.
15:1243–1253. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Bonnans C, Chou J and Werb Z: Remodelling
the extracellular matrix in development and disease. Nat Rev Mol
Cell Biol. 15:786–801. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
46
|
Carmeliet P: Angiogenesis in life, disease
and medicine. Nature. 438:932–936. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kalluri R: The biology and function of
fibroblasts in cancer. Nat Rev Cancer. 16:582–598. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Simian M, Hirai Y, Navre M, Werb Z,
Lochter A and Bissell MJ: The interplay of matrix
metalloproteinases, morphogens and growth factors is necessary for
branching of mammary epithelial cells. Development. 128:3117–3131.
2001.PubMed/NCBI
|
|
49
|
Tsujino T, Seshimo I, Yamamoto H, Ngan CY,
Ezumi K, Takemasa I, Ikeda M, Sekimoto M, Matsuura N and Monden M:
Stromal myofibroblasts predict disease recurrence for colorectal
cancer. Clin Cancer Res. 13:2082–2090. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Sugimoto H, Mundel TM, Kieran MW and
Kalluri R: Identification of fibroblast heterogeneity in the tumor
microenvironment. Cancer Biol Ther. 5:1640–1646. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Erkan M, Michalski CW, Rieder S,
Reiser-Erkan C, Abiatari I, Kolb A, Giese NA, Esposito I, Friess H
and Kleeff J: The activated stroma index is a novel and independent
prognostic marker in pancreatic ductal adenocarcinoma. Clin
Gastroenterol Hepatol. 6:1155–1161. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Shieh AC, Rozansky HA, Hinz B and Swartz
MA: Tumor cell invasion is promoted by interstitial flow-induced
matrix priming by stromal fibroblasts. Cancer Res. 71:790–800.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Crawford Y, Kasman I, Yu L, Zhong C, Wu X,
Modrusan Z, Kaminker J and Ferrara N: PDGF-C mediates the
angiogenic and tumorigenic properties of fibroblasts associated
with tumors refractory to anti-VEGF treatment. Cancer Cell.
15:21–34. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Lazennec G and Richmond A: Chemokines and
chemokine receptors: New insights into cancer-related inflammation.
Trends Mol Med. 16:133–144. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Valcz G, Sipos F, Tulassay Z, Molnar B and
Yagi Y: Importance of carcinoma-associated fibroblast-derived
proteins in clinical oncology. J Clin Pathol. 67:1026–1031. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Shan LH, Sun WG, Han W, Qi L, Yang C, Chai
CC, Yao K, Zhou QF, Wu HM, Wang LF and Liu JR: Roles of fibroblasts
from the interface zone in invasion, migration, proliferation and
apoptosis of gastric adenocarcinoma. J Clin Pathol. 65:888–895.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Elenbaas B and Weinberg RA: Heterotypic
signaling between epithelial tumor cells and fibroblasts in
carcinoma formation. Exp Cell Res. 264:169–184. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
De Monte L, Reni M, Tassi E, Clavenna D,
Papa I, Recalde H, Braga M, Di Carlo V, Doglioni C and Protti MP:
Intratumor T helper type 2 cell infiltrate correlates with
cancer-associated fibroblast thymic stromal lymphopoietin
production and reduced survival in pancreatic cancer. J Exp Med.
208:469–478. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Berdiel-Acer M, Bohem ME, López-Doriga A,
Vidal A, Salazar R, Martínez-Iniesta M, Santos C, Sanjuan X,
Villanueva A and Molleví DG: Hepatic carcinoma-associated
fibroblasts promote an adaptative response in colorectal cancer
cells that inhibit proliferation and apoptosis: Nonresistant cells
die by nonapoptotic cell death. Neoplasia. 13:931–946. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Carmeliet P and Jain RK: Angiogenesis in
cancer and other diseases. Nature. 407:249–257. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Poon RT, Fan ST and Wong J: Clinical
implications of circulating angiogenic factors in cancer patients.
J Clin Oncol. 19:1207–1225. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Folkman J: What is the evidence that
tumors are angiogenesis dependent? J Natl Cancer Inst. 82:4–6.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Weidner N, Carroll PR, Flax J, Blumenfeld
W and Folkman J: Tumor angiogenesis correlates with metastasis in
invasive prostate carcinoma. Am J Pathol. 143:401–409.
1993.PubMed/NCBI
|
|
64
|
Weidner N, Folkman J, Pozza F, Bevilacqua
P, Allred EN, Moore DH, Meli S and Gasparini G: Tumor angiogenesis:
A new significant and independent prognostic indicator in
early-stage breast carcinoma. J Natl Cancer Inst. 84:1875–1887.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Hayashi Y, Tsujii M, Akasaka T, Kato M,
Inoue T, Tsujii Y, Maekawa A, Shinzaki S, Nishida T, Watabe K, et
al: Carcinoma-associated fibroblasts educated by P53-Incompetent
cancer cells contribute tumor growth through angiogenesis.
Gastroenterol. 146 Suppl:S488–S489. 2014. View Article : Google Scholar
|
|
66
|
Orimo A and Weinberg RA: Stromal
fibroblasts in cancer: A novel tumor-promoting cell type. Cell
Cycle. 5:1597–1601. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
De Francesco EM, Lappano R, Santolla MF,
Marsico S, Caruso A and Maggiolini M: HIF-1α/GPER signaling
mediates the expression of VEGF induced by hypoxia in breast cancer
associated fibroblasts (CAFs). Breast Cancer Res. 15:R642013.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Li H, Adachi Y, Yamamoto H, Min Y, Ohashi
H, Ii M, Arimura Y, Endo T, Lee CT, Carbone DP, et al: Insulin-like
growth factor-I receptor blockade reduces tumor angiogenesis and
enhances the effects of bevacizumab for a human gastric cancer cell
line, MKN45. Cancer. 117:3135–3147. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Pinedo HM, Verheul HM, D'Amato RJ and
Folkman J: Involvement of platelets in tumour angiogenesis? Lancet.
352:1775–1777. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Bilen MA, Zurita AJ, Ilias-Khan NA, Chen
HC, Wang X, Kearney AY, Hodges S, Jonasch E, Huang S, Khakoo AY and
Tannir NM: Hypertension and circulating cytokines and angiogenic
factors in patients with advanced non-clear cell renal cell
carcinoma treated with sunitinib: results from a phase II trial.
Oncologist. 20:1140–1148. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Taddei ML, Giannoni E, Comito G and
Chiarugi P: Microenvironment and tumor cell plasticity: An easy way
out. Cancer Lett. 341:80–96. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Hellevik T, Pettersen I, Berg V, Bruun J,
Bartnes K, Busund LT, Chalmers A, Bremnes R and Martinez-Zubiaurre
I: Changes in the secretory profile of NSCLC-associated fibroblasts
after ablative radiotherapy: Potential impact on angiogenesis and
tumor growth. Transl Oncol. 6:66–74. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Tang D, Gao J, Wang S, Ye N, Chong Y,
Huang Y, Wang J, Li B, Yin W and Wang D: Cancer-associated
fibroblasts promote angiogenesis in gastric cancer through
galectin-1 expression. Tumour Biol. 37:1889–1899. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Hara M, Nagasaki T, Shiga K and Takeyama
H: Suppression of cancer-associated fibroblasts and endothelial
Cells by itraconazole in bevacizumab-resistant gastrointestinal
cancer. Anticancer Res. 36:169–177. 2016.PubMed/NCBI
|
|
75
|
Bai YP, Shang K, Chen H, Ding F, Wang Z,
Liang C, Xu Y, Sun MH and Li YY: FGF-1/−3/FGFR4 signaling in
cancer-associated fibroblasts promotes tumor progression in colon
cancer through Erk and MMP-7. Cancer Sci. 106:1278–1287. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Uso M, Jantus-Lewintre E, Bremnes RM,
Calabuig S, Blasco A, Pastor E, Borreda I, Molina-Pinelo S,
Paz-Ares L and Guijarro R: Analysis of the immune microenvironment
in resected non-small cell lung cancer: The prognostic value of
different T lymphocyte markers. Oncotarget. 7:52849–52861. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
He J, Hu Y, Hu M and Li B: Development of
PD-1/PD-L1 Pathway in tumor immune microenvironment and treatment
for non-small cell lung cancer. Sci Rep. 5:131102015. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Whiteside TL: Apoptosis of immune cells in
the tumor microenvironment and peripheral circulation of patients
with cancer: Implications for immunotherapy. Vaccine. 20 Suppl
4:A46–A51. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Flossmann E and Rothwell PM; British
Doctors Aspirin Trial and the UK-TIA Aspirin Trial, : Effect of
aspirin on long-term risk of colorectal cancer: Consistent evidence
from randomised and observational studies. Lancet. 369:1603–1613.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Chan AT, Ogino S and Fuchs CS: Aspirin and
the risk of colorectal cancer in relation to the expression of
COX-2. N Engl J Med. 356:2131–2142. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Haviv I, Polyak K, Qiu W, Hu M and
Campbell I: Origin of carcinoma associated fibroblasts. Cell Cycle.
8:589–595. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Sangai T, Ishii G, Kodama K, Miyamoto S,
Aoyagi Y, Ito T, Magae J, Sasaki H, Nagashima T, Miyazaki M and
Ochiai A: Effect of differences in cancer cells and tumor growth
sites on recruiting bone marrow-derived endothelial cells and
myofibroblasts in cancer-induced stroma. Int J Cancer. 115:885–892.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
De Falco V, Guarino V, Avilla E,
Castellone MD, Salerno P, Salvatore G, Faviana P, Basolo F, Santoro
M and Melillo RM: Biological role and potential therapeutic
targeting of the chemokine receptor CXCR4 in undifferentiated
thyroid cancer. Cancer Res. 67:11821–11829. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Borrello MG, Alberti L, Fischer A,
Degl'innocenti D, Ferrario C, Gariboldi M, Marchesi F, Allavena P,
Greco A, Collini P, et al: Induction of a proinflammatory program
in normal human thyrocytes by the RET/PTC1 oncogene. Pro Natl Acad
Scie USA. 102:14825–14830. 2005. View Article : Google Scholar
|
|
86
|
Ahn S, Cho J, Sung J, Lee JE, Nam SJ, Kim
KM and Cho EY: The prognostic significance of tumor-associated
stroma in invasive breast carcinoma. Tumour Biol. 33:1573–1580.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Martinet L, Garrido I, Filleron T, Le
Guellec S, Bellard E, Fournie JJ, Rochaix P and Girard JP: Human
solid tumors contain high endothelial venules: Association with T-
and B-lymphocyte infiltration and favorable prognosis in breast
cancer. Cancer Res. 71:5678–5687. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Rosenwald A, Wright G, Chan WC, Connors
JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland
EB, Giltnane JM, et al: The use of molecular profiling to predict
survival after chemotherapy for diffuse large-B-cell lymphoma. N
Engl J Med. 346:1937–1947. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Erez N, Glanz S, Raz Y, Avivi C and
Barshack I: Cancer associated fibroblasts express pro-inflammatory
factors in human breast and ovarian tumors. Biochem Biophys Res
Commun. 437:397–402. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Lewis CE and Pollard JW: Distinct role of
macrophages in different tumor microenvironments. Cancer Res.
66:605–612. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Laoui D, Movahedi K, Van Overmeire E, van
den Bossche J, Schouppe E, Mommer C, Nikolaou A, Morias Y, De
Baetselier P and Van Ginderachter JA: Tumor-associated macrophages
in breast cancer: Distinct subsets, distinct functions. Int J Dev
Biol. 55:861–867. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Campbell MJ, Tonlaar NY, Garwood ER, Huo
D, Moore DH, Khramtsov AI, Au A, Baehner F, Chen Y, Malaka DO, et
al: Proliferating macrophages associated with high grade, hormone
receptor negative breast cancer and poor clinical outcome. Breast
Cancer Res Treat. 128:703–711. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Lee AH, Happerfield LC, Bobrow LG and
Millis RR: Angiogenesis and inflammation in invasive carcinoma of
the breast. J Clin Pathol. 50:669–673. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Herrera M, Herrera A, Dominguez G,
Domínguez G, Silva J, García V, García JM, Gómez I, Soldevilla B,
Muñoz C, Provencio M, et al: Cancer-associated fibroblast and M2
macrophage markers together predict outcome in colorectal cancer
patients. Cancer Sci. 104:437–444. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Rolny C, Mazzone M, Tugues S, Laoui D,
Johansson I, Coulon C, Squadrito ML, Segura I, Li X, Knevels E, et
al: HRG inhibits tumor growth and metastasis by inducing macrophage
polarization and vessel normalization through downregulation of
PlGF. Cancer Cell. 19:31–44. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Wada J, Suzuki H, Fuchino R, Yamasaki A,
Nagai S, Yanai K, Koga K, Nakamura M, Tanaka M, Morisaki T and
Katano M: The contribution of vascular endothelial growth factor to
the induction of regulatory T-cells in malignant effusions.
Anticancer Res. 29:881–888. 2009.PubMed/NCBI
|
|
97
|
Tjomsland V, Spångeus A, Välilä J,
Sandström P, Borch K, Druid H, Falkmer S, Falkmer U, Messmer D and
Larsson M: Interleukin 1alpha sustains the expression of
inflammatory factors in human pancreatic cancer microenvironment by
targeting cancer-associated fibroblasts. Neoplasia. 13:664–675.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Roca H, Varsos ZS, Sud S, Craig MJ, Ying C
and Pienta KJ: CCL2 and interleukin-6 promote survival of human
CD11b+ peripheral blood mononuclear cells and induce M2-type
macrophage polarization. J Biol Chem. 284:34342–34354. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Mantovani A: La mala educacion of
tumor-associated macrophages: Diverse pathways and new players.
Cancer cell. 17:111–112. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Tsuyada A, Chow A, Wu J, Somlo G, Chu P,
Loera S, Luu T, Li AX, Wu X, Ye W, et al: CCL2 mediates cross-talk
between cancer cells and stromal fibroblasts that regulates breast
cancer stem cells. Cancer Res. 72:2768–2779. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Augsten M, Hägglöf C, Olsson E, Stolz C,
Tsagozis P, Levchenko T, Frederick MJ, Borg A, Micke P, Egevad L
and Ostman A: CXCL14 is an autocrine growth factor for fibroblasts
and acts as a multi-modal stimulator of prostate tumor growth. Proc
Natl Acad Sci USA. 106:pp. 3414–3419. 2009; View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Byrne SN, Knox MC and Halliday GM: TGFbeta
is responsible for skin tumour infiltration by macrophages enabling
the tumours to escape immune destruction. Immunol Cell Biol.
86:92–97. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Bekeredjian-Ding I, Schäfer M, Hartmann E,
Pries R, Parcina M, Schneider P, Giese T, Endres S, Wollenberg B
and Hartmann G: Tumour-derived prostaglandin E and transforming
growth factor-beta synergize to inhibit plasmacytoid dendritic
cell-derived interferon-alpha. Immunology. 128:439–450. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Weber F, Byrne SN, Le S, Brown DA, Breit
SN, Scolyer RA and Halliday GM: Transforming growth factor-beta1
immobilises dendritic cells within skin tumours and facilitates
tumour escape from the immune system. Cancer Immunol Immunotherap.
54:898–906. 2005. View Article : Google Scholar
|
